BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6610259)

  • 1. [Serum uric acid levels in disorders of the rheumatic type].
    Bosmanský K; Trnavský K
    Z Rheumatol; 1984; 43(2):59-62. PubMed ID: 6610259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uric acid levels of the serum of healthy persons and patients with various rheumatic diseases].
    Bośmanský K; Ondrasík M
    Ter Arkh; 1987; 59(4):22-5. PubMed ID: 3495897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Loss of digital substance in rheumatic diseases. Apropos of 43 cases].
    Huaux JP; Esselinckx W; Meunier H; Dufour JP; Devogelaer JP; Nagant de Deuxchaisnes C
    Rev Rhum Mal Osteoartic; 1987; 54(7-9):549-53. PubMed ID: 3499655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uricemia in various rheumatic diseases in the area of Piestăny].
    Bosmanský K; Hajzoková M
    Fysiatr Revmatol Vestn; 1974 Oct; 52(5):284-8. PubMed ID: 4547734
    [No Abstract]   [Full Text] [Related]  

  • 5. Behaviour of uricemia in hyperlipoproteinemic subjects.
    Zdrenghea D; Marta D; Constantinescu M; Cucuianu M
    Med Interne; 1980; 18(4):385-90. PubMed ID: 7455583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid levels in a population with rheumatic complaints.
    Franco AE; González-Parés EN; Méndez-Bryan R
    Bol Asoc Med P R; 1968 Oct; 60(10):479-85. PubMed ID: 5304457
    [No Abstract]   [Full Text] [Related]  

  • 8. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The causes of death of patients with rheumatic diseases in Moscow].
    Demina AB; Radenska-Lopovok SG; Folomeeva OM; Erdes Sh
    Klin Med (Mosk); 2005; 83(1):36-43. PubMed ID: 15759489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases.
    Denko CW; Malemud CJ
    Semin Arthritis Rheum; 2005 Aug; 35(1):24-34. PubMed ID: 16084221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is hyperuricemia a cardiovascular risk factor?].
    Chizyński K; Rózycka M
    Wiad Lek; 2006; 59(5-6):364-7. PubMed ID: 17017483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uric acid of plasma in patients with rheumatic heart disease, rheumatoid arthritis and systemic lupus erythematosus and its dynamics during treatment].
    Belov VA
    Ter Arkh; 1976; 48(5):96-9. PubMed ID: 948806
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum uric acid levels in some rheumatic diseases (author's transl)].
    Bosmanský K; Trnavský K; Hajzoková M
    Bratisl Lek Listy; 1981 May; 75(5):577-83. PubMed ID: 6972245
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum uric acid levels and the occurrence of hyperuricemia].
    Thiele P; Tellkamp F; Feuerstein C; Heidelmann G
    Z Arztl Fortbild (Jena); 1971 Jun; 65(12):595-600. PubMed ID: 5112870
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
    Tumgor G; Arikan C; Kilic M; Aydogdu S
    Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum beta-endorphin in rheumatic disorders.
    Denko CW; Aponte J; Gabriel P; Petricevic M
    J Rheumatol; 1982; 9(6):827-33. PubMed ID: 7161773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the laboratory in rheumatology. Uric acid and the interpretation of hyperuricaemia.
    Scott JT
    Clin Rheum Dis; 1983 Apr; 9(1):241-55. PubMed ID: 6603324
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of soluble CD44-isoform v5 in rheumatic diseases are restricted to seropositive rheumatoid arthritis.
    Haberhauer G; Kittl EM; Skoumal M; Hübl W; Wagner E; Bayer PM; Bauer K; Dunky A
    Acta Med Austriaca; 1997; 24(1):23-5. PubMed ID: 9150806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.